Oldtime Baseball Game Home 2017-08-17T22:28:54+00:00

Thank You!

Pedro Martinez 2017 oldtime baseball game

For making the 2017 Oldtime Baseball Game one for the ages. Check back soon for photos and game recap.

2017 Beneficiaries

John Martin Oldtme Baseball Game

John Martin Fund

John Martin is a longtime videographer at NESN who has been diagnosed with amyotrophic lateral sclerosis, commonly known as Lou Gehrig’s Disease. He has been with NESN for 19 years, and has been a fixture behind the camera during Red Sox and Bruins telecasts. He was in St. Louis in 2004 when the Red Sox won their first World Series in 86 years, and in Vancouver in 2011 when the Bruins won their first Stanley Cup in 39 years.

Martin and his wife, Adrienne, are the parents of two girls. He also has been involved as a coach in Boston’s fabled South End Little League for 30 years. The John Martin Fund was established to make sure John and his family don’t lose precious time worrying about the financial restraints caused by his diagnosis. To that end, a throng of Martin’s friends in the Boston media, as well as many of his former players from the South End Little League, plan to be in attendance at this year’s Oldtime Baseball Game.

ALS TDI

ALS Therapy Development Institute

The ALS Therapy Development Institute (ALS TDI) is a non-profit biotech and the world’s foremost drug discovery center dedicated to finding a cure for ALS (Amyotrophic Lateral Sclerosis).

Located in the heart of Kendall Square, Cambridge, ALS TDI and its scientists actively discover and develop treatments for ALS. It employs over 30 full-time, industry-trained drug development experts, and has screened over 300 drugs since its inception in 1999. Rated a four-star charity by CharityNavigator.com, ALS TDI spends 87% of each dollar raised on research to find an effective treatment and cure for ALS. ALS TDI is internationally recognized as a leader in optimizing preclinical models of neurodegeneration for clinical translation, and partners with pharmaceutical companies and other biotechs around the world.